Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
87,490,797
-
Share change
-
+330,027
-
Total reported value
-
$10,279,386,005
-
Put/Call ratio
-
86%
-
Price per share
-
$117.49
-
Number of holders
-
228
-
Value change
-
+$76,555,680
-
Number of buys
-
105
-
Number of sells
-
115
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2017
As of 30 Sep 2017,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
228 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,490,797 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, DODGE & COX, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, GOLDMAN SACHS GROUP INC, and PERCEPTIVE ADVISORS LLC.
This page lists
228
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.